|Day's Range||11.85 - 12.40|
|52 Week Range||6.72 - 16.70|
|PE Ratio (TTM)||-14.91|
|Earnings Date||Jul 24, 2017 - Jul 28, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||16.25|
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Unisys Corp. Here are 5 ETFs with the largest exposure to UIS-US. Comparing the performance and risk of Unisys Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Unisys (UIS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BLUE BELL, Pa., May 23, 2017 /PRNewswire/ -- Unisys Corporation (UIS) today launched PharmaTrack, new software that combines leading security, advanced data analytics and compliance technology in a single, unified platform to provide life sciences and healthcare companies enhanced visibility and oversight of the entire global pharmaceutical supply chain and thus help combat theft and counterfeit drugs. This newest addition to the Unisys ActiveInsights™ suite of solutions arose from an overlap of industry needs between two industries in which Unisys has deep domain expertise: life sciences and healthcare, and travel and transportation. "When we starting talking to people involved in pharmaceutical supply chain management, we quickly realized that Unisys already had developed the technologies in other industries required to address longstanding problems in pharmaceuticals," said Jeff R. Livingstone, PhD, vice president and global head, Life Sciences and Healthcare, Unisys.